For some people, getting infected with COVID-19 means more than surviving a mild cold. With certain medical conditions, COVID-19 can become severe and dangerous. Monoclonal antibodies give your body’s immune system the help it needs to destroy the COVID-19 virus.
To get this treatment, you must qualify and have a referral.
Who Can Receive Monoclonal Antibodies?
If you meet the following requirements, talk to your provider about getting a referral. It’s best to get treatment within 7 days of your first symptoms.
You qualify for this treatment if you:
- Had mild to moderate symptoms of COVID-19 in the last 7 days
- Have tested positive for COVID-19
- Have one or more high-risk factors
High-risk factors include:
- Being over 65 years old
- Obesity or being overweight
- Chronic kidney disease
- Immunosuppressive disease and/or medication
- Heart disease or high blood pressure
- Chronic lung disease
- Sickle cell disease
- Neurodevelopmental disorders such as cerebral palsy and learning disabilities
- Medical-related technological dependence, such as tracheostomy, gastrostomy, or positive pressure ventilation
You may not be eligible for monoclonal antibodies if you:
- Are hospitalized with the virus
- Require oxygen therapy due to COVID-19
Getting a Referral
Non-UVA providers can complete this form and fax it to 434.243.9800.
What to Expect at UVA
We provide monoclonal antibody treatment at our dedicated COVID-19 clinic through IV infusion or injection under the skin. Treatment visits last 2-4 hours.
Monoclonal Antibodies for Children
We can help to coordinate with the Infusion Center at the Battle Building to schedule an appointment for children.
Other Medicines We Use to Treat COVID
At UVA Health, we follow the strict guidelines set by the FDA. We use these FDA-approved medications for COVID patients:
- Tocilizumab and baricitinib
Ivermectin & Other Treatments We Don't Use
At UVA Health, we don't treat COVID-19 with:
Studies haven't shown that any of these help with COVID. And the FDA hasn't approved their use for COVID treatment.